Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On January 29, 2009, Zimmer Holdings, Inc. (the "Registrant") reported its
results of operations for the quarter and year ended December 31, 2008. The
Registrant's earnings release is attached as Exhibit 99.1 and the information
set forth therein is incorporated herein by reference and constitutes a part of
this report.
The earnings release attached as Exhibit 99.1 includes two types of
non-GAAP financial measures that differ from financial measures calculated in
accordance with U.S. generally accepted accounting principles ("GAAP"). These
non-GAAP financial measures may not be comparable to similar measures reported
by other companies and should be considered in addition to, and not as a
substitute for, or superior to, other measures prepared in accordance with GAAP.
The first type of non-GAAP financial measure included in the press release
consists of sales information reported on a constant currency basis which has
been calculated by translating actual current and prior-period sales at the same
predetermined exchange rate. The translated results are then used to determine
year-over-year percentage increases or decreases that exclude the effect of
changes in foreign currency exchange rates.
The second type of non-GAAP financial measure included in the press release
consists of operating performance measures that have been adjusted to exclude
certain items. The Registrant has presented adjusted net earnings and adjusted
diluted EPS for the fourth quarter and full year 2008 and projected adjusted
diluted EPS for the full year 2009 to exclude the effects of inventory step-up
and acquisition, integration and other related expenses, including in-process
research and development ("IPR&D") charges associated with the recent
acquisition of Abbott Spine, net of tax. In addition, adjusted net earnings and
adjusted diluted EPS for the fourth quarter and full year 2008 exclude a
provision for known and anticipated claims relating to the previously announced
voluntary suspension of marketing and distribution of the Durom® Acetabular
Component in the U.S., net of tax. Adjusted net earnings and adjusted diluted
EPS for the full year 2008 also exclude an estimated current tax benefit
recorded in the third quarter of 2008 related to the deductibility of the
$169.5 million civil settlement amount paid in September 2007 in connection with
the settlement of a federal investigation.
Adjusted net earnings and adjusted diluted EPS for the 2007 periods
presented in the press release exclude inventory step-up and acquisition,
integration and other related expenses, net of tax. Adjusted net earnings and
adjusted diluted EPS for the full year 2007 also exclude the payment of the
$169.5 million civil settlement amount referred to above.
The items identified above are typically highly variable and of a size that
could have a substantial impact on the Registrant's reported operations for a
period. Management considers the provision related to the Durom Acetabular
Component a non-recurring item that, as explained in the press release, is
qualitatively different from the Registrant's routine product liability claims.
Management uses this non-GAAP information internally to evaluate the
performance of the business and believes that it provides useful information to
investors by offering the ability to make more meaningful period-to-period
comparisons of the Registrant's on-going operating results, the ability to
better identify operating trends that may otherwise be masked or distorted
by these types of items and to perform related trend analysis, and a higher
degree of transparency of certain expenses.
All of the non-GAAP financial measures are reconciled to the most directly
comparable GAAP financial measure in the press release.
The Registrant is furnishing the information contained in this report,
including the Exhibit, pursuant to Item 2.02 of Form 8-K promulgated by the
Securities and Exchange Commission (the "SEC"). This information shall not be
deemed to be "filed" with the SEC or incorporated by reference into any other
filing with the SEC. By filing this report on Form 8-K and furnishing this
information, the Registrant makes no admission as to the materiality of any
information in this report, including the Exhibit.